REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Yuyu Pharma Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Yuyu Pharma Inc. Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

yuyu is a pharmaceutical company. The company specializes in the development of dairy medicines and has a target market in the Korean pharmaceutical business. yuyu operates a customer satisfaction center.

Headquarters
983 Wangam-Dong, Jecheon-Si
Jecheon; Chungcheongbuk; Postal Code: 390-250

Contact Details: Purchase the Yuyu Pharma Inc. report to view the information.

Website: http://www.yuyu.co.kr

Basic Information
Total Employees:
Purchase the Yuyu Pharma Inc. report to view the information.
Outstanding Shares:
Purchase the Yuyu Pharma Inc. report to view the information.
Registered Capital:
Purchase the Yuyu Pharma Inc. report to view the information.
Financial Auditors:
Purchase the Yuyu Pharma Inc. report to view the information.
Incorporation Date:
February 28, 1941
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
18.26%
Purchase this report to view the information.
9.55%
Purchase this report to view the information.
6.95%
Purchase this report to view the information.
4.2%
Purchase this report to view the information.
2.95%
Subsidiaries
(주)유유헬스케어
Company Performance
Financial values in the chart are available after Yuyu Pharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-2.82%▼
Total operating revenue
-0.72%▼
Operating profit (EBIT)
N/A
EBITDA
217.48%▲
Net Profit (Loss) for the Period
N/A
Total assets
-1.26%▼
Total equity
3.92%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-3.77%▼
Quick Ratio
-0.09%▼
Cash Ratio
0.06%▲

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Rpbio Inc.
 
Daehwa Pharm Co.,Ltd.
Hwail Pharm. Co.,Ltd.
 
Humedix Co., Ltd.
Macrogen Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo